3,4-methylenedioxyamphetamine has been researched along with Libman-Sacks Disease in 1 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Excerpt | Relevance | Reference |
---|---|---|
"Individuals with systemic lupus erythematosus (SLE) often experience symptoms that affect family relationships, which are important components of quality of life." | 1.38 | Assessment of health-related family role functioning in systemic lupus erythematosus: preliminary validation of a new measure. ( Buyske, S; Hassett, AL; Katz, PP; Li, T; Radvanski, DC; Savage, SV; Schiff, SA, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hassett, AL | 1 |
Li, T | 1 |
Radvanski, DC | 1 |
Savage, SV | 1 |
Buyske, S | 1 |
Schiff, SA | 1 |
Katz, PP | 1 |
1 other study available for 3,4-methylenedioxyamphetamine and Libman-Sacks Disease
Article | Year |
---|---|
Assessment of health-related family role functioning in systemic lupus erythematosus: preliminary validation of a new measure.
Topics: Activities of Daily Living; Adult; Family Relations; Fatigue; Female; Humans; Love; Lupus Erythemato | 2012 |